INSIGHTS ON DRUG DEVELOPMENT

• Improving Next-Generation Sequencing Workflows With Droplet Digital PCR

  Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.

• Human Skin Explant Model For The Investigation Of Topical Therapeutics

  Learn more about an ex vivo cultured human skin explant model in which pathological tissue integrity, barrier function, and metabolic stability have been characterized over time.

• Modeling Colorectal Cancer Progression

  Gain a better understanding of the microenvironment's role in colorectal cancer progression by reviewing the integration of Organ-Chip models with high-content imaging and mass spectrometry-based metabolomics.

• NanoImprove The Performance Of Your Formulations

  Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

• Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing

  3/20/2026

  Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.

• Liquids, Soft Foods As Vehicles For Enteric Coated Bead Drug Product

  4/10/2024

  Take a deeper look at the challenges and solutions involved in creating a child-friendly medication delivery system, and learn about the importance of collaboration and meticulous scientific processes.

• Validating Antibodies With Knock-Out Technologies

  10/8/2024

  Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.

• Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions

  11/20/2025

  Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.

• Column Selection For RPLC-UV Impurity Analysis

  7/17/2025

  Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.